The immunosuppressive factors IL-10, TGF-β, and VEGF do not affect the antigen-presenting function of CD40-activated B cells

CD40-Activated B Cells Can Efficiently Prime Antigen-Specific Naïve CD8+ T Cells to Generate Effector but Not Memory T cells

(2012) Mélissa Mathieu et al.   PLoS One

Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy

(2011) Takami Sato et al.   IMMUNOLOGIC RESEARCH

The immunoregulatory mechanisms of carcinoma for its survival and development

(2011) Caigan Du et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

CD40-Activated B Cell Cancer Vaccine Improves Second Clinical Remission and Survival in Privately Owned Dogs with Non-Hodgkin's Lymphoma

(2011) Karin U. Sorenmo et al.   PLoS One

TGFß, a Potent Regulator of Tumor Microenvironment and Host Immune Response, Implication for Therapy

(2010) L. Yang   CURRENT MOLECULAR MEDICINE

Biology of interleukin-10

(2010) Robert Sabat et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Guiding the “misguided” - functional conditioning of dendritic cells for the DC-based immunotherapy against tumours

(2010) Fang-Ping Huang et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

The evolving role of dendritic cells in cancer therapy

(2010) EJ Ilett et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Induction of myeloma-specific cytotoxic T lymphocytes ex vivo by CD40-activated B cells loaded with myeloma tumor antigens

(2009) Sang-Ki Kim et al.   ANNALS OF HEMATOLOGY

The role of B cells in the pathogenesis of graft-versus-host disease

(2009) A. Shimabukuro-Vornhagen et al.   BLOOD

Synergistic Enhancement of CD8+ T Cell-Mediated Tumor Vaccine Efficacy by an Anti-Transforming Growth Factor-  Monoclonal Antibody

(2009) M. Terabe et al.   CLINICAL CANCER RESEARCH

Induction of protective cytotoxic T-cell responses by a B-cell-based cellular vaccine requires stable expression of antigen

(2009) S Guo et al.   GENE THERAPY

CD40-activated B cells can be generated in high number and purity in cancer patients: analysis of immunogenicity and homing potential

(2008) E. Kondo et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Efficient antitumor immunity in a murine colorectal cancer model induced by CEA RNA-electroporated B cells

(2008) Mi-Young Park et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

RNA-loaded CD40-activated B cells stimulate antigen-specific T-cell responses in dogs with spontaneous lymphoma

(2008) N J Mason et al.   GENE THERAPY

CD40 Ligand-activated, antigen-specific B cells are comparable to mature dendritic cells in presenting protein antigens and major histocompatibility complex class I- and class II-binding peptides

(2008) Tahamtan Ahmadi et al.   IMMUNOLOGY

Activated B cells modified by electroporation of multiple mRNAs encoding immune stimulatory molecules are comparable to mature dendritic cells in inducingin vitroantigen-specific T-cell responses

(2008) Jaewoo Lee et al.   IMMUNOLOGY

Cancer Immunology

(2008) Olivera J. Finn   NEW ENGLAND JOURNAL OF MEDICINE

Immunosuppressive mechanisms in human tumors: Why we still cannot cure cancer

(2007) Stefanie Gross et al.   IMMUNOLOGY LETTERS